Ozair Alam Selected Research

Ozair Alam Research Topics

Disease

10	Neoplasms (Cancer) 07/2022 - 09/2018
3	COVID-19 05/2022 - 01/2022
3	Epilepsy (Aura) 01/2021 - 01/2017
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 09/2020
2	Breast Neoplasms (Breast Cancer) 10/2020 - 09/2020
1	Aberrant Crypt Foci 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Retinal Degeneration 11/2021
1	Macular Degeneration (Age-Related Maculopathy) 11/2021
1	Myoclonus (Nocturnal Myoclonus) 01/2021
1	Seizures (Absence Seizure) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Prostatic Neoplasms (Prostate Cancer) 10/2020
1	Hyperglycemia 09/2020
1	Cardiomyopathies (Cardiomyopathy) 04/2020
1	Nervous System Diseases (Neurological Disorders) 01/2020
1	Ischemic Stroke 01/2020
1	Disease Progression 01/2020
1	Inflammation (Inflammations) 01/2019
1	Pain (Aches) 01/2019
1	Gout 01/2019
1	Hyperuricemia 01/2019
1	Edema (Dropsy) 12/2018
1	Hypoglycemia (Reactive Hypoglycemia) 04/2018
1	Weight Gain 01/2018

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 07/2022 - 01/2019
2	Biological ProductsIBA 05/2022 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2021 - 04/2020
2	LipidsIBA 01/2020 - 01/2019
2	gamma-Aminobutyric Acid (GABA)IBA 09/2017 - 01/2017
1	Tyrosine Kinase InhibitorsIBA 07/2022
1	neratinibIBA 07/2022
1	Nigella sativa oilIBA 04/2022
1	TubulinIBA 02/2022
1	Dimenhydrinate (DMH)FDA LinkGeneric 01/2022
1	hydrazine (hydrazine dihydrochloride)IBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Antiparasitic Agents (Antiparasitics)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Ivermectin (Mectizan)FDA Link 01/2022
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 11/2021
1	ChitosanIBA 11/2021
1	Sirolimus (Rapamycin)FDA Link 11/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	HMGB1 Protein (HMG1)IBA 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	pyrazoleIBA 01/2021
1	NitrogenIBA 01/2021
1	fisetinIBA 01/2021
1	Neuroprotective AgentsIBA 01/2021
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	imidazopyridineIBA 10/2020
1	sulforaphaneIBA 09/2020
1	pentadecanoic acidIBA 09/2020
1	AntioxidantsIBA 09/2020
1	Estrogens (Estrogen)FDA Link 09/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2020
1	Nonesterified Fatty Acids (NEFA)IBA 09/2020
1	Tamoxifen FDA LinkGeneric 09/2020
1	Palmitic Acid (Hexadecanoic Acid)IBA 09/2020
1	DAPIIBA 04/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2020
1	ErbB Receptors (EGF Receptor)IBA 04/2020
1	SynucleinsIBA 01/2020
1	Monoacylglycerol LipasesIBA 01/2019
1	lesinuradIBA 01/2019
1	EnzymesIBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	Allopurinol (Remid)FDA LinkGeneric 01/2019
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	CarrageenanIBA 12/2018
1	piperidineIBA 09/2018
1	Rosiglitazone (Avandia)FDA Link 04/2018
1	Pioglitazone (Actos)FDA Link 04/2018
1	Blood Glucose (Blood Sugar)IBA 04/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	TriazinesIBA 09/2017
1	pyrimidineIBA 09/2017

Therapy/Procedure

3	Therapeutics 04/2022 - 01/2020